Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVAGINALGeneric

VANOBID

CANDICIDIN

Standard Dose
3MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview VANOBID is listed in Drugs@FDA under application 061613 (ANDA).

Marketing status: Discontinued Active ingredient CANDICIDIN Form and strength TABLET;VAGINAL - 3MG Sponsor SANOFI AVENTIS US Submission history See approval history documents.

Structured Monograph

Clinical summary

Approval overview VANOBID is listed in Drugs@FDA under application 061613 (ANDA). Marketing status: Discontinued Active ingredient CANDICIDIN Form and strength TABLET;VAGINAL - 3MG Sponsor SANOFI AVENTIS US Submission history See approval history documents.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.